Shopping Cart
Remove All
Your shopping cart is currently empty
5-LOx-in-2 is a 5-lipoxygenase inhibitor (5-LOX) with an IC50 value of 0.33 μM. 5-lox-in-2 inhibits 5-LOX action IN a dose-dependent manner. 5-LOX-IN-2 can reduce the cell activity of kidney cancer cells and induce apoptosis, and can be used in cancer research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $31 | - | In Stock | |
| 5 mg | $88 | - | In Stock | |
| 10 mg | $145 | - | In Stock | |
| 25 mg | $308 | - | In Stock | |
| 50 mg | $437 | - | In Stock | |
| 100 mg | $591 | - | In Stock | |
| 200 mg | $810 | - | In Stock |
| Description | 5-LOx-in-2 is a 5-lipoxygenase inhibitor (5-LOX) with an IC50 value of 0.33 μM. 5-lox-in-2 inhibits 5-LOX action IN a dose-dependent manner. 5-LOX-IN-2 can reduce the cell activity of kidney cancer cells and induce apoptosis, and can be used in cancer research. |
| Targets&IC50 | 5-LOX:0.33 μM |
| In vitro | 5-LOX-IN-2 at a concentration of 0-100 μM, after 4 days of action, reduced the activity of renal cancer cells (RCC4, RCC10, 786.0 cells) and showed higher selectivity for RCC4 and 786.0 cells deficient in the von Hippel-Lindau (VHL) tumor suppressor gene. 5-LOX-IN-2 at a concentration of 0-10 μM, after 24 hours of action, was capable of increasing the expression of LC3B and p62, and inducing apoptosis through the activation of the caspase-3 pathway. concentration and after 24 hours of action, it was able to increase the expression of LC3B and p62, block the autophagic flow in RCC4 cells, and induce apoptosis by activating the caspase-3 pathway. |
| Molecular Weight | 284.31 |
| Formula | C17H16O4 |
| Cas No. | 179691-97-5 |
| Smiles | C(=C/C(OCCC1=CC=CC=C1)=O)\C2=C(O)C=CC(O)=C2 |
| Relative Density. | 1.266 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (175.86 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (7.03 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.